<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>shareholdersunite.com &#187; DNDN</title>
	<atom:link href="http://shareholdersunite.com/category/dndn/feed/" rel="self" type="application/rss+xml" />
	<link>http://shareholdersunite.com</link>
	<description>Opportunities in smallcaps</description>
	<lastBuildDate>Tue, 07 Feb 2012 10:50:42 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<!-- added to the content header -->	<item>
		<title>Soros buys big into Dendreon</title>
		<link>http://shareholdersunite.com/2010/11/18/dndn/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dndn</link>
		<comments>http://shareholdersunite.com/2010/11/18/dndn/#comments</comments>
		<pubDate>Thu, 18 Nov 2010 18:26:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[DNDN]]></category>

		<guid isPermaLink="false">http://shareholdersunite.com/2010/11/18/dndn/</guid>
		<description><![CDATA[Some corners will probably say his aim it to blow-up US healthcare cost (it doesn&#8217;t need Soros for that, but anyway)..Wednesday&#8217;s Vote Will Determine Dendreon&#8217;s Fate By Brandon Rowley A Medicare advisory panel is scheduled to vote tomorrow on whether to accept Dendreon Corporation&#8217;s (NASDAQ:DNDN) prostate cancer drug, Provenge. The fate of the company &#8211; [...]]]></description>
		<wfw:commentRss>http://shareholdersunite.com/2010/11/18/dndn/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What to buy? Gamble on biotech stocks</title>
		<link>http://shareholdersunite.com/2009/05/25/biotech-stocks/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biotech-stocks</link>
		<comments>http://shareholdersunite.com/2009/05/25/biotech-stocks/#comments</comments>
		<pubDate>Mon, 25 May 2009 15:42:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[ARNA]]></category>
		<category><![CDATA[BCRX]]></category>

		<guid isPermaLink="false">http://shareholdersunite.com/?p=1167</guid>
		<description><![CDATA[The regulatory approval process for new drugs is Byzantine, lengthy, and unpredictable. Single stocks are, for outsiders at least (even insiders can be surprised), almost pure bets. But one can still profit from the usual fact that the winnings are often much larger than the possible losses&#8230; Such an approach would involve taking a portfolio [...]]]></description>
		<wfw:commentRss>http://shareholdersunite.com/2009/05/25/biotech-stocks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dendreon&#8217;s Provenge blockbuster opportunity</title>
		<link>http://shareholdersunite.com/2009/05/21/dendreon-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dendreon-2</link>
		<comments>http://shareholdersunite.com/2009/05/21/dendreon-2/#comments</comments>
		<pubDate>Thu, 21 May 2009 02:42:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[DNDN]]></category>

		<guid isPermaLink="false">http://shareholdersunite.com/?p=1154</guid>
		<description><![CDATA[We&#8217;re a bit frustrated, as we the things we follow had quite a run, but now we don&#8217;t trust the markets anymore, to be honest. We&#8217;re looking for things that could be relatively immune to a market fall. This could be one of them, we already wrote about this company. The one problem we have, [...]]]></description>
		<wfw:commentRss>http://shareholdersunite.com/2009/05/21/dendreon-2/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Dendreon&#8217;s dramatic day</title>
		<link>http://shareholdersunite.com/2009/04/29/dendreon/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dendreon</link>
		<comments>http://shareholdersunite.com/2009/04/29/dendreon/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 04:14:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[DNDN]]></category>

		<guid isPermaLink="false">http://shareholdersunite.com/?p=1056</guid>
		<description><![CDATA[Now here is real drama, both on the medical front and in the markets. Dendreon (DNDN), you have probably heared about it. The stock was all over the place today as trading was halted after a very short but very steep fall. Then when trading resumed, the stock more than doubled, and when the mist [...]]]></description>
		<wfw:commentRss>http://shareholdersunite.com/2009/04/29/dendreon/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
	<!-- added to the content footer --></channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.shareholdersunite.com @ 2012-02-07 05:57:43 -->
